Breaking News Instant updates and real-time market news.

RARE

Ultragenyx

$82.98

4.33 (5.51%)

09:55
08/29/18
08/29
09:55
08/29/18
09:55

Piper ups Ultragenyx target to $89 on 'surprise' UX007 filing acceptance

Piper Jaffray analyst Christopher Raymond raised his price target for Ultragenyx Pharmaceutical to $89 from $85 on news that FDA has accepted the company's proposal to submit for approval of UX007 in long-chain fatty acid oxidation disorders, based on existing data. The news pulls commercialization forward by upwards of one year plus, Raymond tells investors in a research note titled "Surprise, Surprise! FDA Appears Fine With Early Trihep FAOD Filing." He points out that management's overall tone on the potential for filing early was very cautious. The analyst thinks many investors will be surprised by today's development and that shares will react favorably. Raymond keeps an Overweight rating on Ultragenyx.

  • 12

    Sep

  • 12

    Sep

RARE Ultragenyx
$82.98

4.33 (5.51%)

08/03/18
PIPR
08/03/18
NO CHANGE
Target $85
PIPR
Overweight
Ultragenyx price target raised to $85 from $67 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond raised his price target for Ultragenyx to $85 and keeps an Overweight rating on the shares following the company's Q2 update. It looks like the launch of Crysvita is going well, Raymond tells investors in a research note. He continues to like the setup for the stock and would be buyers at current levels.
08/03/18
LEHM
08/03/18
NO CHANGE
Target $92
LEHM
Overweight
Ultragenyx price target raised to $92 from $74 at Barclays
Barclays analyst Gena Wang raised her price target for Ultragenyx to $92 saying the company for Q2 reported encouraging initial launch metrics for Crysvita in the U.S. The analyst sees multiple catalysts in the second half of 2018, including continued Crysvita commercial launch, clinical readouts from gene therapy programs DTX301 and DTX401, and regulatory feedback for UX007 in LC-FAOD. She reiterates an Overweight rating on Ultragenyx.
08/06/18
WEDB
08/06/18
NO CHANGE
Target $80
WEDB
Outperform
Ultragenyx price target raised to $80 from $71 at Wedbush
Wedbush analyst David Nierengarten raised his price target for Ultragenyx to $80 from $71 after the company reported a solid start to Crysvita sales in the U.S., with rate of adult adoption and reimbursement particularly encouraging for potential growth opportunity. The analyst reiterates an Outperform rating on the shares.
08/20/18
RHCO
08/20/18
NO CHANGE
Target $83
RHCO
Buy
Ultragenyx price target raised to $83 from $69 at SunTrust
SunTrust analyst Edward Nash raised his price target on Ultragenyx to $83 and kept his Buy rating, saying the second half of 2018 should be "catalyst-rich" for the company. The analyst notes that he expects an E.U. approval for Mepsevii following a positive CHMP opinion along with two gene therapy programs, stating that these could be "significant value drivers" for the Ultragenyx stock.

TODAY'S FREE FLY STORIES

UNFI

United Natural Foods

$33.87

0.575 (1.73%)

16:12
09/20/18
09/20
16:12
09/20/18
16:12
Hot Stocks
Breaking Hot Stocks news story on United Natural Foods »

United Natural Foods down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

UNFI

United Natural Foods

$33.79

0.5 (1.50%)

16:12
09/20/18
09/20
16:12
09/20/18
16:12
Hot Stocks
United Natural Foods says results reflect higher than anticipated freight costs »

"We continued to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

SCS

Steelcase

$16.10

0.8 (5.23%)

16:11
09/20/18
09/20
16:11
09/20/18
16:11
Hot Stocks
Breaking Hot Stocks news story on Steelcase »

Steelcase up 9.9% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

FATE

Fate Therapeutics

$13.99

0.64 (4.79%)

16:11
09/20/18
09/20
16:11
09/20/18
16:11
Syndicate
Fate Therapeutics files to sell common stock, no amount given »

Jefferies, Piper Jaffray,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SCS

Steelcase

$16.10

0.8 (5.23%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Earnings
Breaking Earnings news story on Steelcase »

Steelcase sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

T

AT&T

$33.38

0.02 (0.06%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Hot Stocks
AT&T recommends that shareholders reject mini-tender from Ponos Industries »

AT&T has learned that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

BHBK

Blue Hills Bancorp

$23.50

0.35 (1.51%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Hot Stocks
Breaking Hot Stocks news story on Blue Hills Bancorp »

Blue Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KPTI

Karyopharm

$18.98

0.49 (2.65%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
Karyopharm announces oral presentation relating to selinexor »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SCS

Steelcase

$16.05

0.75 (4.90%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Earnings
Steelcase sees Q3 EPS 28c-33c, consensus 25c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

UNFI

United Natural Foods

$33.89

0.6 (1.80%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
United Natural Foods reports Q4 gross margin 14.5% down 125 bps y/y »

Gross margin for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

OPNT

Opiant Pharmaceuticals

$22.41

0.36 (1.63%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
Opiant Pharmaceuticals enters into $4.6M contract with BARDA for OPTN003 »

Opiant Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UNFI

United Natural Foods

$33.92

0.63 (1.89%)

16:08
09/20/18
09/20
16:08
09/20/18
16:08
Hot Stocks
United Natural Foods sees FY19 effective tax rate 27.4%-28.4% »

Sees FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

SCS

Steelcase

$16.05

0.75 (4.90%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Earnings
Steelcase reports Q2 EPS 41c, consensus 29c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

EDR

EdR

$41.49

(0.00%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Hot Stocks
EdR acquired by Greystar Real Estate for $4.6B »

EdR's acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$33.87

0.58 (1.74%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Earnings
United Natural Foods sees FY19 adjusted EPS $3.48-$3.58, consensus $3.54 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

MU

Micron

$45.97

0.92 (2.04%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron notes Q4 cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

ADBE

Adobe

$266.64

1.73 (0.65%)

16:06
09/20/18
09/20
16:06
09/20/18
16:06
Hot Stocks
Adobe to acquire Marketo for $4.75B »

Adobe announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

16:05
09/20/18
09/20
16:05
09/20/18
16:05
Earnings
United Natural Foods reports Q4 adjusted EPS 76c, consensus 85c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

ASM

Avino Silver & Gold Mines

$0.81

-0.0486 (-5.65%)

16:05
09/20/18
09/20
16:05
09/20/18
16:05
Syndicate
Avino Silver & Gold Mines files to sell common stock and warrants »

H.C. Wainwright & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

MU

Micron

$45.98

0.93 (2.06%)

16:04
09/20/18
09/20
16:04
09/20/18
16:04
Hot Stocks
Micron notes secular, diversified growth drivers to drive results »

"Micron delivered an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

MU

Micron

$46.08

1.03 (2.29%)

16:03
09/20/18
09/20
16:03
09/20/18
16:03
Earnings
Micron reports Q4 EPS $3.53, consensus $3.34 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

TXN

Texas Instruments

$108.49

1.13 (1.05%)

16:02
09/20/18
09/20
16:02
09/20/18
16:02
Hot Stocks
Texas Instruments raises dividend 24%, announces $12B share repurchase plan »

Texas Instruments said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$108.48

1.12 (1.04%)

16:01
09/20/18
09/20
16:01
09/20/18
16:01
Hot Stocks
Breaking Hot Stocks news story on Texas Instruments »

Texas Instruments raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$0.00

(0.00%)

15:58
09/20/18
09/20
15:58
09/20/18
15:58
Periodicals
Uber in early talks to buy Deliveroo in Europe, Bloomberg says »

Uber is in early stage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDR

EdR

$41.49

(0.00%)

15:57
09/20/18
09/20
15:57
09/20/18
15:57
Hot Stocks
Breaking Hot Stocks news story on EdR »

Education Realty trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.